Kenneth C Anderson

58PUBLICATIONS

349CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMicroelectromechanical systems (MEMS)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (58)

Sort by Publication Date:

|Jul 15, 2026

The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma.

|Jul 08, 2026

WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

|Apr 20, 2026

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Feb 04, 2026

Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations.

Annamaria Gullà, Madhav V Dhodapkar, Hermann Einsele

|Dec 11, 2025

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma.

Anil Aktas Samur, Jill Corre, Srikanth Talluri

|Oct 17, 2025

ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

Pageof 10

Frequent Collaborators

18 joint publications

Nikhil Munshi

13 joint publications

Yu-Tzu Tai

13 joint publications

Mehmet Samur

10 joint publications

Keith T Flaherty

10 joint publications

Massimo Loda

9 joint publications

Lewis C Cantley

9 joint publications

Riccardo Dalla-Favera

9 joint publications

Raymond N DuBois

9 joint publications

Chi Van Dang

9 joint publications

Luis A Diaz

Frequent Collaborators

18 joint publications

Nikhil Munshi

13 joint publications

Yu-Tzu Tai

13 joint publications

Mehmet Samur

10 joint publications

Keith T Flaherty